SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-010958
Filing Date
2020-02-05
Accepted
2020-02-05 06:50:24
Documents
18
Period of Report
2020-02-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm206551-1_8k.htm   iXBRL 8-K 36910
2 EXHIBIT 99.1 tm206551d1_ex99-1.htm EX-99.1 593997
3 EXHIBIT 99.2 tm206551d1_ex99-2.htm EX-99.2 645653
4 EXHIBIT 99.3 tm206551d1_ex99-3.htm EX-99.3 37829
9 GRAPHIC tm20655d1_ex99-1img01.jpg GRAPHIC 11736
10 GRAPHIC tm20655d1_ex99-3img01.jpg GRAPHIC 11736
  Complete submission text file 0001104659-20-010958.txt   1673796

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mrk-20200205.xsd EX-101.SCH 4497
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20200205_def.xml EX-101.DEF 28711
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20200205_lab.xml EX-101.LAB 39013
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20200205_pre.xml EX-101.PRE 27320
19 EXTRACTED XBRL INSTANCE DOCUMENT tm206551-1_8k_htm.xml XML 8801
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 20576334
SIC: 2834 Pharmaceutical Preparations